A Phase I, Open-Label, Randomized Cross-Over, 2-Period, 2-Way Interaction Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-State in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 May 2012
At a glance
- Drugs Etravirine; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 01 May 2012 Results published in the Journal of Clinical Pharmacology.
- 11 Nov 2009 Results were presented at EACS 2009.
- 09 Oct 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.